-
1 Comment
LiDCO Group Plc is currently in a long term uptrend where the price is trading 62.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.6.
Based on the above factors, LiDCO Group Plc gets an overall score of 2/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | None |
Industry | Medical Devices |
Sector | Healthcare |
Market Cap | 28M |
---|---|
Target Price | None |
Dividend Yield | 0.0% |
PE Ratio | 22.21 |
Beta | -0.03 |
LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company provides LiDCOunity, a hemodynamic monitor to support clinical decision making; LiDCOrapid, a monitor that analyses the blood pressure waveform to provide information in surgical and critically ill patients to help with fluid and drug management; LiDCOview that offers clinical researchers and users with beat-to-beat hemodynamic data; LiDCOplus, a hemodynamic monitor, which provides assessment of the hemodynamic status of critical care and surgery patients; and accessories, including blood pressure modules. It also offers various closed and open pressure monitoring sets for use in the ICU, operating department, and Cath labs; and Stimpod NMS 450X, a quantitative neuromuscular blocking agent monitor. LiDCO Group Plc was founded in 1991 and is headquartered in London, the United Kingdom. As of January 11, 2021, LiDCO Group Plc operates as a subsidiary of Masimo Corporation.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LDG.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025